https://www.selleckchem.com/products/ml385.html
1 (mRECIST, respectively). ADC values increased significantly ( 0.005) after TARE in the PR group whereas there was no significant change in the PD group. Post-therapeutic ADC values of SD lesions increased significantly when evaluated by RECIST 1.1 but not if evaluated by mRECIST. Percentual changes of ADC values were slightly higher for responders compared to non-responders ( 0.05). ADC values seem to represent an additional marker for treatment response evaluation after TARE in patients with secondary hepatic NET. A conclusive